South Korea Proton Therapy Market to Nearly Triple by 2021, States Renub Research in Its New Study Available at MarketPublishers.com11 Apr 2017 • by Natalie Aster
LONDON – South Korea’s proton therapy market is anticipated to nearly triple by 2021 from its market size of over USD 1 billion as of 2016. Proton therapy plays a vital role in providing comprehensive cancer treatment to adults and kids at the National Cancer Center in Korea.
Technological upgrades to proton therapy, that has increased utilisation ratio, are projected to reduce the amount of time per patient, which will likely further give a boost to the domestic proton therapy market. However, requirement of huge investments and also operational challenges could hinder the market growth.
To date, however, there are only a small number of proton therapy centers that can treat a small subset of patients every year.
In-demand research publication “Korea Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Therapy Centers & Forecast” elaborated by Renub Research provides an all-round assessment of the actual (current) market, and also examines the untapped proton therapy market that can possibly be achieved.
The report provides an analysis of the country’s proton therapy actual and untapped market plus forecasts, examining treated patient volume and forecasted data for both markets. It includes a listing of local proton therapy centers; provides information on the treated patients by centers; gives an all-round overview of the reimbursement policies pertaining to the proton therapy marketplace. The study includes a discussion of the various components of a standard proton therapy center. It sheds light on the key market drivers and challenges. Furthermore, the report canvasses the competitive scenario and includes a granular analysis of the dominant companies, such as IBA, Varian Medical Systems and Elekta.
Data are provided from 2009 and up to 2021.
More in-demand research reports elaborated by Renub Research are available its page at MarketPublishers.com.